By Business/Source
Currency:USD
2023/FY
Stock NameRevenueRatio
Single segment1.1M100.00%
By Country/Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States1.1M100.00%
US Stock MarketDetailed Quotes
Matinas BioPharma (MTNB)
- 0.6990
- +0.0486+7.47%
Close May 1 16:00 ET
- 0.6601
- -0.0389-5.57%
Post 20:01 ET
4.48MMarket Cap-0.35P/E (TTM)
0.6990High0.6350Low34.51KVolume0.6600Open0.6504Prev Close22.90KTurnover0.66%Turnover RatioLossP/E (Static)6.41MShares3.090052wk High0.93P/B3.66MFloat Cap0.480052wk Low--Dividend TTM5.23MShs Float197.5000Historical High--Div Yield TTM9.84%Range %0.4748Historical Low0.6636Avg Price1Lot Size
Matinas BioPharma (MTNB) Revenue Breakdown Overview
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm